Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Czarina N Behrends

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|September 3, 2020
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US CitiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2020
"Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus EpidemicBohdan Nosyk, Emanuel Krebs, Xiao Zang, et al.
The International Journal on Drug Policy|August 17, 2022
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectivesElizabeth J Austin, Maria A Corcorran, Elsa S Briggs, et al.
Journal of Addiction Medicine|August 2, 2022
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 VaccineMaria A Corcorran, Elizabeth J Austin, Czarina N Behrends, et al.
Harm Reduction Journal|July 19, 2022
Responding to a surge in overdose deaths: perspectives from US syringe services programsMadeline C Frost, Elizabeth J Austin, Maria A Corcorran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 15, 2026
Impact of COVID-19 on late HIV diagnosis rates by race/ethnicity in Ending the HIV Epidemic (EHE) priority jurisdictions in the United StatesQiyou Wu, Sayyeda Karim, Minh-Tri Van, et al.
Trials|April 24, 2022
M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
The International Journal on Drug Policy|December 6, 2025
A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six statesZongbo Li, Tanvi V Chiddawar, Leah C Shaw, et al.
Harm Reduction Journal|December 8, 2025
One voice and vision: How the RISE network built a collective identity as the foundation for strategic disseminationElizabeth Troutman Adams, R Craig Lefebvre, Mia-Cara Christopher, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|September 3, 2020
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US CitiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2020
"Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus EpidemicBohdan Nosyk, Emanuel Krebs, Xiao Zang, et al.
The International Journal on Drug Policy|August 17, 2022
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectivesElizabeth J Austin, Maria A Corcorran, Elsa S Briggs, et al.
Journal of Addiction Medicine|August 2, 2022
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 VaccineMaria A Corcorran, Elizabeth J Austin, Czarina N Behrends, et al.
Harm Reduction Journal|July 19, 2022
Responding to a surge in overdose deaths: perspectives from US syringe services programsMadeline C Frost, Elizabeth J Austin, Maria A Corcorran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 15, 2026
Impact of COVID-19 on late HIV diagnosis rates by race/ethnicity in Ending the HIV Epidemic (EHE) priority jurisdictions in the United StatesQiyou Wu, Sayyeda Karim, Minh-Tri Van, et al.
Trials|April 24, 2022
M<sup>2</sup>HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWIDValérie Martel-Laferrière, Daniel J Feaster, Lisa R Metsch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
The International Journal on Drug Policy|December 6, 2025
A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six statesZongbo Li, Tanvi V Chiddawar, Leah C Shaw, et al.
Harm Reduction Journal|December 8, 2025
One voice and vision: How the RISE network built a collective identity as the foundation for strategic disseminationElizabeth Troutman Adams, R Craig Lefebvre, Mia-Cara Christopher, et al.
Pageof 5